Fibroblast models of neurological disorders: fluorescence measurement studies

被引:54
作者
Connolly, GP [1 ]
机构
[1] United Med & Dent Sch Guys & St Thomas Hosp, Guys Hosp, Neurosci Grp, Purine Neurosci Lab,Div Chem Pathol, London SE1 9RT, England
关键词
D O I
10.1016/S0165-6147(98)01202-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biochemical studies of human fibroblasts from patients with neurological disorders have revealed a wealth of information on how such disorders occur. In this review, Gerald Connolly describes how recently developed fluorescence video imaging techniques have been used to study the physiology of skin fibroblasts isolated from patients with certain neurological disorders, including those produced by Alzheimer's disease, Lesch-Nyhan syndrome, mitochondrial disorders, amyotrophic lateral sclerosis and lysosomal disorders. The results of these studies indicate disruptions in cell homeostasis, particularly specific changes in Ca2+ homeostasis and autofluorescence, which mirror changes thought to occur in the CNS of neurologically impaired patients. More extensive studies of these 'systemic changes' using new fluorescent indicators, combined with advances in imaging techniques, are predicted to increase the potential usefulness of human skin fibroblasts as experimental models and to help diagnose and treat neurological disorders.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 35 条
  • [1] ALTMAN J, 1995, MOL MED TODAY, V43, P404
  • [2] DO DEFECTS IN MITOCHONDRIAL ENERGY-METABOLISM UNDERLIE THE PATHOLOGY OF NEURODEGENERATIVE DISEASES
    BEAL, MF
    HYMAN, BT
    KOROSHETZ, W
    [J]. TRENDS IN NEUROSCIENCES, 1993, 16 (04) : 125 - 131
  • [3] Metabolic disorders and neurotoxicology
    Beal, MF
    [J]. CURRENT OPINION IN NEUROLOGY, 1995, 8 (06) : 467 - 468
  • [4] JUVENILE NEURONAL CEROID-LIPOFUSCINOSIS - CHARACTERIZATION OF THE DYSLIPOPROTEINEMIA AND DEMONSTRATION OF MEMBRANE PHOSPHOLIPID AND PHOSPHOLIPID-DEPENDENT SIGNAL-TRANSDUCTION ABNORMALITIES IN CULTURED SKIN FIBROBLASTS
    BENNETT, MJ
    POIRIER, SF
    CHERN, L
    GAYTON, AR
    HOSKING, GP
    LE, NA
    MAJUMDAR, S
    KORCHAK, HM
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (02) : 308 - 311
  • [5] Blass J P, 1994, J Neural Transm Suppl, V44, P87
  • [6] CYTOSOLIC-FREE [CA2+] IN MONONUCLEAR BLOOD-CELLS FROM DEMENTED PATIENTS AND HEALTHY CONTROLS
    BONDY, B
    KLAGES, U
    MULLERSPAHN, F
    HOCK, C
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1994, 243 (05) : 224 - 228
  • [7] EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION
    CITRON, M
    VIGOPELFREY, C
    TEPLOW, DB
    MILLER, C
    SCHENK, D
    JOHNSTON, J
    WINBLAD, B
    VENIZELOS, N
    LANNFELT, L
    SELKOE, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) : 11993 - 11997
  • [8] DYKEN PR, 1982, PRACTICE PEDIAT NEUR, P902
  • [9] POTASSIUM CHANNEL DYSFUNCTION IN FIBROBLASTS IDENTIFIES PATIENTS WITH ALZHEIMER-DISEASE
    ETCHEBERRIGARAY, R
    ITO, E
    OKA, K
    TOFELGREHL, B
    GIBSON, GE
    ALKON, DL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 8209 - 8213
  • [10] SOLUBLE BETA-AMYLOID INDUCTION OF ALZHEIMERS PHENOTYPE FOR HUMAN FIBROBLAST K+ CHANNELS
    ETCHEBERRIGARAY, R
    ITO, E
    KIM, CS
    ALKON, DL
    [J]. SCIENCE, 1994, 264 (5156) : 276 - 279